- Home
- TOI
as 05-30-2025 4:00pm EST
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | CERRITOS |
| Market Cap: | 266.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.13 - $3.50 | Next Earning Date: | 05-14-2025 |
| Revenue: | $403,152,000 | Revenue Growth: | 17.64% |
| Revenue Growth (this year): | 23.95% | Revenue Growth (next year): | N/A |
Latest The Oncology Institute Inc. News
TOI Breaking Stock News: Dive into TOI Ticker-Specific Updates for Smart Investing
Simply Wall St.
13 days ago
Oncology Institute And 2 Other Promising Penny Stocks To Watch
Simply Wall St.
16 days ago
Oncology Institute First Quarter 2025 Earnings: US$0.25 loss per share (vs US$0.22 loss in 1Q 2024)
GlobeNewswire
17 days ago
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance
GlobeNewswire
17 days ago
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer
GlobeNewswire
18 days ago
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference
GlobeNewswire
24 days ago
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates
Simply Wall St.
a month ago
The Oncology Institute, Inc.'s (NASDAQ:TOI) largest shareholders are retail investors with 40% ownership, private equity firms own 24%
Insider Monkey
a month ago
Why The Oncology Institute, Inc. (TOI) is Surging in 2025
Compare TOI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TOI The Oncology Institute Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.